⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Kaplan Fox Reminds ARS Pharmaceuticals Inc. (SPRY) Investors of a Securities Class Action Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Levi & Korsinsky Reminds ARS Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - SPRY
prnewswire.com
SPRY
Faruqi & Faruqi, LLP Urges ARS Pharmaceuticals (SPRY) Investors to Seek Counsel Before the October 5, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Contact Levi & Korsinsky to Join Class Action Before October 5, 2026
accessnewswire.com
SPRY
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline
accessnewswire.com
SPRY
Class Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY) - Join by October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 - ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
SPRY